Cargando…

Phase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603

BACKGROUND: Ramucirumab is a human IgG1 monoclonal vascular endothelial growth factor receptor-2 antibody that inhibits tumor cell growth and affects the tumor cell microenvironment. We assessed the efficacy and safety of ramucirumab plus irinotecan combination therapy as second-line treatment in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawamoto, Yasuyuki, Yuki, Satoshi, Sawada, Kentaro, Nakamura, Michio, Muto, Osamu, Sogabe, Susumu, Shindo, Yoshiaki, Ishiguro, Atsushi, Sato, Atsushi, Tsuji, Yasushi, Dazai, Masayoshi, Okuda, Hiroyuki, Meguro, Takashi, Harada, Kazuaki, Sekiguchi, Mari, Okada, Kazufumi, Ito, Yoichi M, Sakata, Yuh, Sakamoto, Naoya, Komatsu, Yoshito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Gastrointestinal Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355819/ https://www.ncbi.nlm.nih.gov/pubmed/35579511 http://dx.doi.org/10.1093/oncolo/oyac086

Ejemplares similares

Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan and S-1 (OX-IRIS) as first-line treatment for metastatic or relapsed pancreatic cancer
por: Nakano, Shintaro, et al.
Publicado: (2022)

Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101)
por: Harada, Kazuaki, et al.
Publicado: (2023)

Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201)
por: Kawamoto, Yasuyuki, et al.
Publicado: (2022)

Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies
por: Nakatsumi, Hiroshi, et al.
Publicado: (2022)

Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer
por: Kawamoto, Yasuyuki, et al.
Publicado: (2017)

A Phase I Trial of Oxaliplatin, Irinotecan, and S‐1 Combination Therapy (OX‐IRIS) as Chemotherapy for Unresectable Pancreatic Cancer (HGCSG 1403)
por: Kawamoto, Yasuyuki, et al.
Publicado: (2021)

Extended RAS Analysis of the Phase III EPIC Trial: Irinotecan + Cetuximab Versus Irinotecan as Second‐Line Treatment for Patients with Metastatic Colorectal Cancer
por: Sobrero, Alberto, et al.
Publicado: (2020)

Initial Report of Second‐Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi‐Institutional Retrospective Analysis
por: Klempner, Samuel J., et al.
Publicado: (2018)

Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study
por: Nakamura, Michio, et al.
Publicado: (2022)

Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective study
por: Nakano, Shintaro, et al.
Publicado: (2020)

Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non–Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2
por: Finn, Richard S, et al.
Publicado: (2022)

The Plague of 1603 in England
por: Mullett, Charles F.
Publicado: (1937)

Toluca, 1603 : vista de ojos /
por: Hernández Rodríguez, Rosaura
Publicado: (1997)

Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study
por: Burtness, Barbara, et al.
Publicado: (2016)

Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial
por: Lipsyc-Sharf, Marla, et al.
Publicado: (2022)

Omental herniation through the esophageal hiatus: A rare cause of gastric outlet obstruction and its CT findings
por: Tanaka, Yoshikazu, et al.
Publicado: (2020)

Large bowel obstruction caused by urinary retention from benign prostate hyperplasia
por: Fujisaki, Tomohiro, et al.
Publicado: (2018)

The century of revolution, 1603-1714 /
por: Hill, Christopher, 1912-2003
Publicado: (1982)

Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer
por: Ito, Ken, et al.
Publicado: (2022)

Public Health in Norway 1603–2003
por: HUBBARD, WILLIAM H
Publicado: (2006)

Protocolo de Cabildo 1603-1896
Publicado: (1999)

H. M. FIRST PHYSICIANS, 1603–1844
Publicado: (1967)

Padua and the Tudors: English students in Italy, 1485–1603
por: Nutton, Vivian
Publicado: (2000)

Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane
por: Satake, Hironaga, et al.
Publicado: (2018)

Cost-Effectiveness Analysis of Transanal Irrigation for Managing Neurogenic Bowel Dysfunction in Japan
por: Sengoku, Atsushi, et al.
Publicado: (2018)

A note on Thomas Lodge's A Treatise of the Plagues (1603).
por: Roberts, R S
Publicado: (1978)

Local staging of rectal cancer: the current role of MRI
por: Klessen, Christian, et al.
Publicado: (2006)

New coil concept for endoluminal MR imaging: Initial results in staging of gastric carcinoma in correlation with Histopathology
por: Heye, Tobias, et al.
Publicado: (2006)

Better Survival in Patients with Esophageal Cancer After Surgical Treatment in University Hospitals: A Plea for Performance by Surgical Oncologists
por: Verhoef, Christian, et al.
Publicado: (2007)

Feasibility study of computed tomography colonography using limited bowel preparation at normal and low-dose levels study
por: Florie, Jasper, et al.
Publicado: (2007)

CT colonography: optimisation, diagnostic performance and patient acceptability of reduced-laxative regimens using barium-based faecal tagging
por: Taylor, Stuart A., et al.
Publicado: (2007)

Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis
por: de Haan, Margriet C., et al.
Publicado: (2011)

Small Bowel Obstruction from Capsule Endoscopy
por: Boysen, Megan, et al.
Publicado: (2010)

Boerhaave’s Syndrome
por: Smith, J. Shaun, et al.
Publicado: (2010)

Polyp measurement based on CT colonography and colonoscopy: variability and systematic differences
por: de Vries, Ayso H., et al.
Publicado: (2009)

Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies
por: Zijta, Frank M., et al.
Publicado: (2009)

Profiles of US and CT imaging features with a high probability of appendicitis
por: van Randen, A., et al.
Publicado: (2010)

Long-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience
por: Zhao, Jun-Gong, et al.
Publicado: (2009)

Primary uncleansed 2D versus primary electronically cleansed 3D in limited bowel preparation CT-colonography. Is there a difference for novices and experienced readers?
por: de Vries, Ayso H., et al.
Publicado: (2009)

Delayed Presentation of Sigmoid Volvulus in a Young Woman
por: Weingrow, Daniel, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_av6rnfdp0jrt90bbb27fai2b4u